Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
| Total | Transactions | Amount |
| Buys | 0 | $0 |
| Sells | 12 | $8,244,783 |
| Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
| 30 Jan 2025 12:18 | APLS | Apellis Pharmaceuticals Inc | TOWNSEND ADAM J. | Chief Commercial Officer | 29 Jan 2025 | Sale | 695 | 29.5236 | 20,519 | D |
| 23 Jan 2025 15:39 | APLS | Apellis Pharmaceuticals Inc | TOWNSEND ADAM J. | Chief Commercial Officer | 22 Jan 2025 | Sale | 3,323 | 30.4255 | 101,104 | D |
| 21 Jan 2025 16:12 | APLS | Apellis Pharmaceuticals Inc | TOWNSEND ADAM J. | Chief Commercial Officer | 17 Jan 2025 | Sale | 2,201 | 29.9582 | 65,938 | D |
| 14 Jan 2025 16:29 | APLS | Apellis Pharmaceuticals Inc | TOWNSEND ADAM J. | Chief Commercial Officer | 13 Jan 2025 | Sale | 2,685 | 28.7021 | 77,065 | D |
| 13 Feb 2024 17:05 | APLS | Apellis Pharmaceuticals Inc | TOWNSEND ADAM J. | Chief Commercial Officer | 12 Feb 2024 | Sale | 1,148 | 67.7669 | 77,796 | D |
| 31 Jan 2024 16:36 | APLS | Apellis Pharmaceuticals Inc | TOWNSEND ADAM J. | Chief Commercial Officer | 29 Jan 2024 | Sale | 906 | 64.1382 | 58,109 | D |
| 23 Jan 2024 18:15 | APLS | Apellis Pharmaceuticals Inc | TOWNSEND ADAM J. | Chief Commercial Officer | 22 Jan 2024 | Sale | 3,413 | 64.996 | 221,831 | D |
| 17 Jan 2024 16:37 | APLS | Apellis Pharmaceuticals Inc | TOWNSEND ADAM J. | Chief Commercial Officer | 16 Jan 2024 | Sale | 2,235 | 66.8086 | 149,317 | D |
| 05 Dec 2023 19:29 | APLS | Apellis Pharmaceuticals Inc | TOWNSEND ADAM J. | Chief Commercial Officer | 01 Dec 2023 | Sale | 67,557 | 60.5019 | 4,087,327 | D |
| 05 Dec 2023 19:29 | APLS | Apellis Pharmaceuticals Inc | TOWNSEND ADAM J. | Chief Commercial Officer | 01 Dec 2023 | Sale | 42,443 | 61.3052 | 2,601,977 | D |
| 04 May 2023 16:40 | APLS | Apellis Pharmaceuticals Inc | TOWNSEND ADAM J. | Chief Commercial Officer | 03 May 2023 | Sale | 5,000 | 82.71 | 413,550 | D |
| 05 Apr 2023 16:50 | APLS | Apellis Pharmaceuticals Inc | TOWNSEND ADAM J. | Chief Commercial Officer | 03 Apr 2023 | Sale | 5,000 | 74.05 | 370,250 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)